El-Rayes D
ORCID: 0009-0004-7447-6340
· 1 paper in corpus
nonrandomized-trial
2025
PURPOSE: To evaluate exemestane, an aromatase inhibitor, as a preventive intervention for endometrial cancer. EXPERIMENTAL DESIGN: This is a multicenter, single-arm, "window of opportunity" pilot study of exemestane (25 mg daily for 21-42 …